| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.2M | +19.6% |
| Cost of Revenue | $833K | -2.3% |
| Gross Profit | $1.4M | +38.2% |
| R&D Expense | $1.7M | -0.8% |
| SG&A Expense | $6.2M | +11.8% |
| Operating Income | -$6.5M | -4.1% |
| Interest Expense | $22K | +0.0% |
| Income Tax | $0 | — |
| Net Income | -$6.4M | -3.2% |
| EPS (Basic) | -$1.95 | +78.0% |
| EPS (Diluted) | -$1.95 | +78.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.6M | +479.6% |
| Short-term Investments | $994K | — |
| Accounts Receivable | $201K | -40.0% |
| Inventory | $994K | +25.2% |
| Current Assets | $10.1M | +257.7% |
| Total Assets | $12.8M | +291.8% |
| Current Liabilities | $798K | +42.2% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.8M | +4.7% |
| Capital Expenditures | $138K | +64.3% |
| Investing Cash Flow | -$1.1M | -1867.9% |
| Financing Cash Flow | $13.1M | +555.7% |
| Free Cash Flow | -$5.9M | +3.7% |
| $3.3M |
| +327.0% |
| Stockholders' Equity | $9.6M | +281.0% |